Journal Report

Expert Opinion on Orphan Drugs

Download PDF
Journal Information
Journal Title
Expert Opinion on Orphan Drugs
Publisher
TAYLOR & FRANCIS LTD
ISSN
2167-8707
E-ISSN
2167-8707
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026
2025
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Emerging therapies against <i>Naegleria fowleri</i>
Ruqaiyyah Siddiqui, David Lloyd, Ahmad M. Alharbi et al.
2024-7-31 Vol. 12 Issue 1 Pages 41-49
DOI: 10.1080/21678707.2024.2383173
Management of pulmonary hypertension in infants
Angeline Darren, Christopher Harris, Anne Greenough
2024-7-27 Vol. 12 Issue 1 Pages 33-40
DOI: 10.1080/21678707.2024.2383172
Current and emerging therapies for the treatment of leishmaniasis
Shyam Sundar, Jitendra Singh, Vishal Kumar Singh et al.
2024-4 Vol. 12 Issue 1 Pages 19-32
DOI: 10.1080/21678707.2024.2335248
The Orphan Drug Act and rare cancers: a retrospective analysis of oncologic orphan drug designations and associated approvals from 1983-2022
Abraham Viju Ipe, Lewis J. Fermaglich, Selma Kraft et al.
2024-3-26 Vol. 12 Issue 1 Pages 12-18
DOI: 10.1080/21678707.2024.2333245
Orphan drugs approved in Canada: health technology assessment, price negotiation, and government formulary listing
Nigel S B. Rawson, John Adams
2024-2-13 Vol. 12 Issue 1 Pages 1-11
DOI: 10.1080/21678707.2024.2313766
Overview of genetic testing in Prader-Willi syndrome
Ying Gao, Mian-Lin Zhong, Yang-Li Dai et al.
2023-9-28 Vol. 11 Issue 1 Pages 16-25
DOI: 10.1080/21678707.2023.2262104
Real world data for rare diseases research: The beginner’s guide to registries
Federica Pisa, Ariel Arias, Emily Bratton et al.
2023-8 Vol. 11 Issue 1 Pages 9-15
DOI: 10.1080/21678707.2023.2241347
Recommendations for the management of diarrhea with trofinetide use in Rett syndrome
Eric D. Marsh, Arthur Beisang, Timothy Buie et al.
2023-6-13 Vol. 11 Issue 1 Pages 1-8
DOI: 10.1080/21678707.2023.2217328
Making orphan drugs and services available and accessible for people who live with rare diseases: what has been done? a systematic scoping review
Hesam Ghiasvand, Maxwell S. Barnish, Tayebeh Moradi et al.
2022-12-2 Vol. 10 Issue 1 Pages 55-64
DOI: 10.1080/21678707.2022.2153671
Risdiplam as an orphan drug treatment of spinal muscular atrophy in adults and children (2 months or older)
N. Deconinck, E. Devos
2022-12-2 Vol. 10 Issue 1 Pages 65-72
DOI: 10.1080/21678707.2022.2152671
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 06:25